Clinical Trials - Addiction services in Minnesota - Mayo Clinic
COVID-19 consejos información actualizada y opciones de vacunas
Infórmate sobre la COVID-19 y las vacunas contra esta enfermedad, y conoce las novedades para pacientes y visitantes de Mayo Clinic. Para navegación del sitio Para acceso a contenido Este contenido no tiene una versión en inglés Este contenido no tiene una versión en árabe Departamentos y centros Servicios contra las adicciones
Clinical Trials
A continuación, se enumeran los ensayos clínicos actuales.
7 estudios en Servicios contra las adicciones
(solo estudios abiertos). Filtra esta lista de estudios por sede, estatus, etc. A Study to Analyze the Effects of Buprenorphine on Hyperalgesia in Patients with Opioid Use Disorder
Rochester, Minn. The purpose of this study is to investigate the effects of buprenorphine on hyperalgesia (HP) perception in adults undergoing treatment for opioid use disorder (OUD). A Study to Evaluate Smartphone-based Digital Phenotyping for Relapse Prediction in Alcohol-associated Liver Disease
Rochester, Minn. The primary aim of this study is to define a comprehensive digital phenotype that predicts risk for near-future relapse or relapse in alcohol use in patients with alcohol-associated liver disease. The secondary aim of this study is to assess the relationship between this digital phenotype and markers of disease severity outcome, including MELD score and readmission rates. Acamprosate Treatment Outcome
Rochester, Minn., Albert Lea, Minn. The purpose of this project is to identify biomarkers by discovery of genomic and metabolomic markers associated with response to acamprosate treatment. To achieve this we will use "pharmacometabolomics-informed pharmacogenomics" such as generation a panel of iPSCs (stem cells) to discover biomarkers. A new prospective randomized placebo-controlled trial of 3 month long treatment with acamprosate/placebo will provide new biospecimens, in addition to previously collected biospecimens, to enable the search for genetic and metabolomic biomarkers associated with sobriety or relapse in participants of this new study. A Study to Evaluate AAV8-human Cocaine Hydrolase to Treat Cocaine Use Disorder
Rochester, Minn. The purpose of this study is to see if an experimental agent, when given to subjects who wish to abstain from cocaine, will decrease their craving for cocaine and prevent them from relapsing and returning to cocaine use. This experimental agent is called AAV8-hCocH; and it is a gene modified viral vector. We want to determine the safety of its use in adults who have a cocaine use disorder in sustained remission. Attitudes and Beliefs About Gene Transfer Therapy in Adults with Cocaine Use Disorder
Rochester, Minn. The purpose of this study is to investigate the facilitators and barriers of adults with a history of cocaine use disorder (CocUD) in sustained remission to participating in a Phase I gene transfer study aimed at reducing the rate of cocaine relapse. A Study to Evaluate the Safety Tolerability and Effectiveness of V117957 in Subjects with Insomnia Associated with Alcohol Cessation
Rochester, Minn. The purpose of this study is to evaluate the safety, tolerability and effectiveness of V117957, compared to placebo, in subjects with alcohol use disorder (AUD) who experience insomnia associated with alcohol cessation. A Study to Analyse the Genetic Makeup of Those with Opioid and Substance Use Disorders
Rochester, Minn., Albert Lea, Minn. The purpose of this study is to establish an opioid and multiple addiction (OMA) biobank that creates a comprehensive standard patient phenotype using standardized subjective assessments and objective behavioral measurements for future research. Otros temas en atención en Mayo Clinic
Consultas Ubicación Guía para pacientes y visitantes Servicios internacionales Departamentos y centros médicos Doctores y personal médico Servicios en línea para pacientes Facturación y seguros Ensayos clínicos Colaboraciones comerciales internacionales Información sobre Mayo Clinic Contáctenos . Departamentos y centros Psiquiatría y psicología Servicios contra las adicciones Clinical Trials Mayo Clinic Footer
Para consultasPara donarContáctanosMayo Clinic: InformaciónEmpleadosMapa del sitioSobre el sitio Legal Conditions and Terms
Cualquier uso de este sitio constituye su acuerdo con los términos y condiciones y política de privacidad para los que hay enlaces abajo. Términos y condiciones Política de privacidad Aviso de prácticas en cuanto a privacidad Para administrar cookies Advertising
Mayo Clinic es una organización sin fines de lucro, y el dinero recaudado con la publicidad en Internet apoya nuestra misión. Mayo Clinic no respalda ningún producto ni servicios de terceros que se anuncien.Política sobre publicidad y promociónOportunidades para publicidad y promoción Reprint Permissions
Se puede reimprimir una sola copia de estos materiales para usar en forma personal y no comercial. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," y el triple escudo que es el logotipo de Mayo Clinic son marcas registradas de Mayo Foundation for Medical Education and Research. 1998-2022 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.